Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Filleron

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
European Journal of Radiology|December 28, 2017
Comparing sensitivity and specificity of medical imaging tests when verification bias is present: The concept of relative diagnostic accuracyThomas Filleron
Bulletin Du Cancer|December 15, 2015
[Propensity score: A credible alternative to randomization?]Thomas Filleron, Fabrice Kwiatowski
Bulletin Du Cancer|June 28, 2016
[Erratum to "Propensity score: A credible alternative to randomization?" [Bull. Cancer 103 (2014) 113-22]]Thomas Filleron, Fabrice Kwiatkowski
European Urology|April 29, 2023
Reply to Binghao Zhao, Ruidong Zhang, and Jiaming Wu's Letter to the Editor re: Ana Cavillon, Damien Pouessel, Nadine Houédé, et al. Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.011Ana Cavillon, Raphael Porcher, Thomas Filleron
Computer Methods and Programs in Biomedicine|March 13, 2012
Designing group sequential randomized clinical trials with time to event end points using a R functionThomas Filleron, Jocelyn Gal, Andrew Kramar
JAMA Network Open|February 19, 2026
Target Trial Emulation-A Unifying Approach for Causal Inference From Observational DataNoémie Simon-Tillaux, Aldrine Manzanilla, Thomas Filleron
Chinese Clinical Oncology|May 12, 2021
Drug development in the era of precision medicine in oncology-Clues beyond randomizationPauline du Rusquec, Thomas Filleron, Christophe Le Tourneau
Annals of Nuclear Medicine|November 23, 2014
Measurement of inter- and intra-observer variability in the routine clinical interpretation of brain 18-FDG PET-CTNicolas Brucher, Ramin Mandegaran, Thomas Filleron, et al.
The Breast Journal|May 16, 2017
Impact of surgery on survival in stage IV breast cancerThomas Filleron, Elvire Pons, Amélie Lusque, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 2005
Optimization of follow-up timing from study of patterns of first failure after primary treatment. An example from patients with NSCLC: a study of the REACT working group of ESTROOzlem Uruk Ataman, Ann Barrett, Thomas Filleron, et al.
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
European Journal of Radiology|December 28, 2017
Comparing sensitivity and specificity of medical imaging tests when verification bias is present: The concept of relative diagnostic accuracyThomas Filleron
Bulletin Du Cancer|December 15, 2015
[Propensity score: A credible alternative to randomization?]Thomas Filleron, Fabrice Kwiatowski
Bulletin Du Cancer|June 28, 2016
[Erratum to "Propensity score: A credible alternative to randomization?" [Bull. Cancer 103 (2014) 113-22]]Thomas Filleron, Fabrice Kwiatkowski
European Urology|April 29, 2023
Reply to Binghao Zhao, Ruidong Zhang, and Jiaming Wu's Letter to the Editor re: Ana Cavillon, Damien Pouessel, Nadine Houédé, et al. Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.011Ana Cavillon, Raphael Porcher, Thomas Filleron
Computer Methods and Programs in Biomedicine|March 13, 2012
Designing group sequential randomized clinical trials with time to event end points using a R functionThomas Filleron, Jocelyn Gal, Andrew Kramar
JAMA Network Open|February 19, 2026
Target Trial Emulation-A Unifying Approach for Causal Inference From Observational DataNoémie Simon-Tillaux, Aldrine Manzanilla, Thomas Filleron
Chinese Clinical Oncology|May 12, 2021
Drug development in the era of precision medicine in oncology-Clues beyond randomizationPauline du Rusquec, Thomas Filleron, Christophe Le Tourneau
Annals of Nuclear Medicine|November 23, 2014
Measurement of inter- and intra-observer variability in the routine clinical interpretation of brain 18-FDG PET-CTNicolas Brucher, Ramin Mandegaran, Thomas Filleron, et al.
The Breast Journal|May 16, 2017
Impact of surgery on survival in stage IV breast cancerThomas Filleron, Elvire Pons, Amélie Lusque, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 2005
Optimization of follow-up timing from study of patterns of first failure after primary treatment. An example from patients with NSCLC: a study of the REACT working group of ESTROOzlem Uruk Ataman, Ann Barrett, Thomas Filleron, et al.
Pageof 20